HIV evolution and diversity in ART-treated patients.

about

Modeling HIV persistence and cure studies Insight into treatment of HIV infection from viral dynamics models

P2860

Q57163191-359DC7DF-832D-4E20-B6E8-EDAC58F749E0 Q58788145-5EA97F58-28D4-42E5-B2B0-3CB8A6B27D8E

P2860

HIV evolution and diversity in ART-treated patients.

Item

http://www.wikidata.org/entity/Q47548221

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

HIV evolution and diversity in ART-treated patients.

@en

HIV evolution and diversity in ART-treated patients.

@nl

type

Item

label

HIV evolution and diversity in ART-treated patients.

@en

HIV evolution and diversity in ART-treated patients.

@nl

prefLabel

HIV evolution and diversity in ART-treated patients.

@en

HIV evolution and diversity in ART-treated patients.

@nl

P1476

HIV evolution and diversity in ART-treated patients.

@en

P2093

Michael J Bale

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells

Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure

HIV-1 reverse transcription

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia

Viral population estimation using pyrosequencing

The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial

Antibody neutralization and escape by HIV-1

P2888

s12977-018-0395-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S12977-018-0395-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mary Kearney

Gert U Van Zyl

P5008

ScienceSource

P577

2018-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100689290

http://www.w3.org/2001/XMLSchema#string

P698

29378595

http://www.w3.org/2001/XMLSchema#string

P921

human immunodeficiency virus infectious disease

Retroviridae infectious disease

genetic variation

Añaw

P932

5789667

http://www.w3.org/2001/XMLSchema#string

HIV evolution and diversity in ART-treated patients.

about

P2860

P2860

HIV evolution and diversity in ART-treated patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P433

P478

P50

P5008

P577

P6179

P698

P921

P932